These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21345874)

  • 41. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.
    Hong A; Jones D; Chatfield M; Lee CS; Zhang M; Clark J; Elliott M; Harnett G; Milross C; Rose B
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S450-8. PubMed ID: 23208131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry.
    Park K; Cho KJ; Lee M; Yoon DH; Kim J; Kim SY; Nam SY; Choi SH; Roh JL; Han MW; Lee SW; Song SY; Back JH; Kim SB
    Acta Otolaryngol; 2013 Mar; 133(3):297-304. PubMed ID: 23130632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma.
    Velez Torres JM; Alkathery T; Tjendra Y; Zuo Y; Kerr DA; Gomez-Fernandez C
    Cancer Cytopathol; 2023 Mar; 131(3):165-170. PubMed ID: 36350307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
    Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
    Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.
    Qureishi A; Mawby T; Fraser L; Shah KA; Møller H; Winter S
    Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2675-2683. PubMed ID: 28285422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry.
    Drumheller B; Cohen C; Lawson D; Siddiqui MT
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):160-164. PubMed ID: 28777152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis.
    Svajdler M; Nemcova J; Dubinsky P; Metelkova A; Svajdler P; Straka Ľ; Sakar R; Daum O; Michal M; Skalova A; Mezencev R
    Neoplasma; 2020 Nov; 67(6):1456-1463. PubMed ID: 32853018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.
    Wilczynski SP; Lin BT; Xie Y; Paz IB
    Am J Pathol; 1998 Jan; 152(1):145-56. PubMed ID: 9422532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.
    Singhi AD; Westra WH
    Cancer; 2010 May; 116(9):2166-73. PubMed ID: 20186832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
    Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
    Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
    Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity.
    El-Mofty SK; Lu DW
    Am J Surg Pathol; 2003 Nov; 27(11):1463-70. PubMed ID: 14576481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
    Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil.
    Li W; Thompson CH; O'Brien CJ; McNeil EB; Scolyer RA; Cossart YE; Veness MJ; Walker DM; Morgan GJ; Rose BR
    Int J Cancer; 2003 Sep; 106(4):553-558. PubMed ID: 12845651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
    Huho AN; Yadak N; Bocklage TJ; Yang S
    J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.